Are prions transported by plasma exosomes?

Transfusion and Apheresis Science

Volumn 55, Issue 1, 2016, Pages 70-83

  Cervenakova, Larisa ^a   Saá, Paula ^a   Yakovleva, Oksana ^a,b   Vasilyeva, Irina ^a   de Castro, Jorge ^a,c   Brown, Paul ^d   Dodd, Roger ^a  

^a Off of Clinical Laboratory Affairs   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Meso Scale Discovery   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood; Extracellular vesicles; Plasma; Prion infectivity; Prion protein

Indexed keywords

NANOPARTICLE; PROTEINASE K; PRION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD COMPONENT; BRAIN HOMOGENATE; CELL CULTURE; CELL ISOLATION; CELL LYSATE; CONTROLLED STUDY; DISEASE TRANSMISSION; EXOSOME; FEMALE; HISTOLOGY; MOUSE; NONHUMAN; PRION; PROTEIN TRANSPORT; REVIEW; SPLEEN CELL; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; BLOOD; CREUTZFELDT JAKOB DISEASE; GENETICS; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; METABOLISM;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; EXOSOMES; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; MICE; MICE, TRANSGENIC; PRIONS; PROTEIN TRANSPORT;

EID: 84983516293     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2016.07.013     Document Type: Review

References (85)

1. [1] Diack, A.B., Head, M.W., McCutcheon, S., Boyle, A., Knight, R., Ironside, J.W., et al. Variant CJD. 18 years of research and surveillance. Prion 8 (2014), 286–295 Epub 2014 Nov 1.
2. [2] Brandel, J.P., Peckeu, L., Haïk, S., The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol 20 (2013), 395–397 Epub 2013 Apr 12.
3. [3] Knight, R., The risk of transmitting prion disease by blood or plasma products. Transfus Apher Sci 43 (2010), 387–391 Epub 2010 Nov 11.
4. [4] Peden, A., McCardle, L., Head, M.W., Love, S., Ward, H.J., Cousens, S.N., et al. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16 (2010), 296–304 Epub 2010 Jan 12.
5. [5] Jackson, G.S., Burk-Rafel, J., Edgeworth, J.A., Sicilia, A., Abdilahi, S., Korteweg, J., et al. A highly specific blood test for vCJD. Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study. JAMA Neurol 71 (2014), 421–428.
6. [6] Jackson, G.S., Burk-Rafel, J., Edgeworth, J.A., Sicilia, A., Abdilahi, S., Korteweg, J., et al. Detection of prion infection in variant Creutzfeldt- Jakob disease: a blood-based assay. Blood 123 (2014), 452–453.
7. [7] Edgeworth, J.A., Farmer, M., Sicilia, A., Tavares, P., Beck, J., Campbell, T., et al. Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377 (2011), 487–493.
8. [8] Lacroux, C., Comoy, E., Moudjou, M., Perret-Liaudet, A., Lugan, S., Litaise, C., et al. Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog, 10, 2014, e1004202.
9. [9] Rubenstein, R., Chang, B., Re-assessment of PrP(Sc) distribution in sporadic and variant CJD. PLoS ONE, 8, 2013 e66352.
10. [10] Wadsworth, J.D., Joiner, S., Hill, A.F., Campbell, T.A., Desbruslais, M., Luthert, P.J., et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358 (2001), 171–180.
11. [11] Ironside, J.W., Bishop, M.T., Connolly, K., Hegazy, D., Lowrie, S., Le Grice, M., et al. Variant Creutzfeldt-Jakob disease: prion protein genotype 21 analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332 (2006), 1186–1188 Epub 2006 Apr 10. Erratum in: BMJ. 2006;333:416.
12. [12] de Marco, M.F., Linehan, J., Gill, O.N., Clewley, J.P., Brandner, S., Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 222 (2010), 380–387.
13. [13] Wadsworth, J.D., Dalmau-Mena, I., Joiner, S., Linehan, J.M., O'Malley, C., Powell, C., et al. Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study. J Pathol 223 (2011), 511–518 Epub 2010 Dec 10.
14. [14] Gill, O.N., Spencer, Y., Richard-Loendt, A., Kelly, C., Dabaghian, R., Boyes, L., et al. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ, 347, 2013, f5675.
15. [15] Brown, P., Cervenáková, L., Diringer, H., Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease. J Lab Clin Med 137 (2001), 5–13 Review. No abstract available. Erratum in: J Lab Clin Med 2001;137:230.
16. [16] Bannach, O., Birkmann, E., Reinartz, E., Jaeger, K.E., Langeveld, J.P., Rohwer, R.G., et al. Detection of prion protein particles in blood plasma of scrapie infected sheep. PLoS ONE, 7, 2012 e36620. Epub 2012 May 2.
17. [17] Halliez, S., Jaumain, E., Huor, A., Douet, J.Y., Lugan, S., Cassard, H., et al. White blood cell-based detection of asymptomatic scrapie infection by ex vivo assays. PLoS ONE, 9, 2014 e104287.
18. [18] Dassanayake, R.P., Truscott, T.C., Zhuang, D., Schneider, D.A., Madsen-Bouterse, S.A., Young, A.J., et al. Classical natural ovine scrapie prions detected in practical volumes of blood by lamb and transgenic mouse bioassays. J Vet Sci 16 (2015), 179–186 Epub 2014 Dec 24.
19. [19] Lacroux, C., Vilette, D., Fernández-Borges, N., Litaise, C., Lugan, S., Morel, N., et al. Prionemia and leukocyte-platelet-associated infectivity in sheep transmissible spongiform encephalopathy models. J Virol 86 (2012), 2056–2066 Epub 2011 Dec 7.
20. [20] Mathiason, C.K., Powers, J.G., Dahmes, S.J., Osborn, D.A., Miller, K.V., Warren, R.J., et al. Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314 (2006), 133–136.
21. [21] Mathiason, C.K., Hayes-Klug, J., Hays, S.A., Powers, J., Osborn, D.A., Dahmes, S.J., et al. B cells and platelets harbor prion infectivity in the blood of deer infected with chronic wasting disease. J Virol 84 (2010), 5097–5107 Epub 2010 Mar 10.
22. [22] Pillonel, J., Brandel, J.P., Léon, L., Salomon, D., Haïk, S., Capek, I., et al. Preclinical sporadic Creutzfeldt-Jakob disease in French blood donors: an epidemiologic model-based study. Transfusion 52 (2012), 1290–1295 Epub 2011 Dec 1.
23. [23] Dorsey, K., Zou, S., Schonberger, L.B., Sullivan, M., Kessler, D., Notari, E. 4th, et al. Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study. Transfusion 49 (2009), 977–984 Epub 2009 Jan 5.
24. [24] Brown, P., Gibbs, C.J. Jr, Rodgers-Johnson, P., Asher, D.M., Sulima, M.P., Bacote, A., et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35 (1994), 513–529.
25. [25] Brown, P., The risk of blood-borne Creutzfeldt–Jakob disease. Dev Biol (Basel) 102 (2000), 53–59 Review.
26. [26] Cervenakova, L., Brown, P., Soukharev, S., Yakovleva, O., Diringer, H., Saenko, E.L., et al. Failure of immunocompetitive capillary electrophoresis assay to detect disease-specific prion protein in buffy coat from humans and chimpanzees with Creutzfeldt-Jakob disease. Electrophoresis 24 (2003), 853–859.
27. [27] Douet, J.Y., Zafar, S., Perret-Liaudet, A., Lacroux, C., Lugan, S., Aron, N., et al. Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg Infect Dis 20 (2014), 114–117.
28. [28] Prusiner, S.B., Novel proteinaceous infectious particles cause scrapie. Science 216 (1982), 136–144.
29. [29] Oesch, B., Westaway, D., Wälchli, M., McKinley, M.P., Kent, S.B., Aebersold, R., et al. A cellular gene encodes scrapie PrP 27–30 protein. Cell 40 (1985), 735–746.
30. [30] Völkel, D., Zimmermann, K., Zerr, I., Bodemer, M., Lindner, T., Turecek, P.L., et al. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases. Transfusion 41 (2001), 441–448.
31. [31] Brown, P., Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy. Haemophilia 13:Suppl. 5 (2007), 33–40.
32. [32] Saborio, G.P., Permanne, B., Soto, C., Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411 (2001), 810–813.
33. [33] Soto, C., Anderes, L., Suardi, S., Cardone, F., Castilla, J., Frossard, M.J., et al. Pre-symptomatic detection of prions by cyclic amplification of protein misfolding. FEBS Lett 579 (2005), 638–642.
34. [34] Atarashi, R., Wilham, J.M., Christensen, L., Hughson, A.G., Moore, R.A., Johnson, L.M., et al. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 5 (2008), 211–212.
35. [35] Atarashi, R., Satoh, K., Sano, K., Fuse, T., Yamaguchi, N., Ishibashi, D., et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17 (2011), 175–178 Epub 2011 Jan 30.
36. [36] Orrú, C.D., Wilham, J.M., Raymond, L.D., Kuhn, F., Schroeder, B., Raeber, A.J., et al. Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio, 2, 2011 e00078-11.
37. [37] Elder, A.M., Henderson, D.M., Nalls, A.V., Wilham, J.M., Caughey, B.W., Hoover, E.A., et al. In vitro detection of prionemia in TSE-infected cervids and hamsters. PLoS ONE, 8, 2013 e80203.
38. [38] Elder, A.M., Henderson, D.M., Nalls, A.V., Hoover, E.A., Kincaid, A.E., Bartz, J.C., et al. Immediate and ongoing detection of prions in the blood of hamsters and deer following oral, nasal, or blood inoculations. J Virol 89 (2015), 7421–7424.
39. [39] Henderson, D.M., Manca, M., Haley, N.J., Denkers, N.D., Nalls, A.V., Mathiason, C.K., et al. Rapid antemortem detection of CWD prions in deer saliva. PLoS ONE, 8, 2013 e74377.
40. [40] Saá, P., Cervenakova, L., Protein misfolding cyclic amplification (PMCA): current status and future directions. Virus Res 207 (2015), 47–61 Epub 2014 Nov 13.
41. [41] Saá, P., Castilla, J., Soto, C., Ultra-efficient replication of infectious prions by automated protein misfolding cyclic amplification. J Biol Chem 281 (2006), 35245–35252 Epub 2006 Sep 18.
42. TSE) in extracellular vesicles from plasma of mice infected with mouse-adapted variant Creutzfeldt-Jakob disease by in vitro amplification. J Biol Chem 289 (2014), 29247–29260 Epub 2014 Aug 25.
43. [43] Yáñez-Mó, M., Siljander, P.R.-M., Andreu, Z., Zavec, A.B., Borràs, F.E., Buzas, E.I., et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles, 4, 2015, 27066 Epub 2015 May 14.
44. [44] Raposo, G., Stoorvogel, W., Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200 (2013), 373–383.
45. [45] Coleman, B.M., Hill, A.F., Extracellular vesicles – their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases. Semin Cell Dev Biol 40 (2015), 89–96 Epub 2015 Feb 20. Review.
46. [46] Chivet, M., Hemming, F., Pernet-Gallay, K., Fraboulet, S., Sadoul, R., Emerging role of neuronal exosomes in the central nervous system. Front Physiol, 3, 2012, 145.
47. [47] Fevrier, B., Vilette, D., Archer, F., Loew, D., Faigle, W., Vidal, M., et al. Cells release prions in association with exosomes. Proc Natl Acad Sci USA 101 (2004), 9683–9688 Epub 2004 Jun 21.
48. [48] Vella, L.J., Sharples, R.A., Lawson, V.A., Masters, C.L., Cappai, R., Hill, A.F., Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol 211 (2007), 582–590.
49. [49] Alais, S., Simoes, S., Baas, D., Lehmann, S., Raposo, G., Darlix, J.L., et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 100 (2008), 603–615.
50. [50] Vilette, D., Laulagnier, K., Huor, A., Alais, S., Simoes, S., Maryse, R., et al. Efficient inhibition of infectious prions multiplication and release by targeting the exosomal pathway. Cell Mol Life Sci 72 (2015), 4409–4427 Epub 2015 Jun 6.
51. [51] Arellano-Anaya, Z.E., Huor, A., Leblanc, P., Lehmann, S., Provansal, M., Raposo, G., et al. Prion strains are differentially released through the exosomal pathway. Cell Mol Life Sci 72 (2015), 1185–1196 Epub 2014 Sep 18.
52. C trafficking to PrPsc propagation. Blood Cells Mol Dis 35 (2005), 143–148 Review.
53. [53] Robertson, C., Booth, S.A., Beniac, D.R., Coulthart, M.B., Booth, T.F., McNicol, A., Cellular prion protein is released on exosomes from activated platelets. Blood 107 (2006), 3907–3911 Epub 2006 Jan 24.
54. [54] Ritchie, A.J., Crawford, D.M., Ferguson, D.J., Burthem, J., Roberts, D.J., Normal prion protein is expressed on exosomes isolated from human plasma. Br J Haematol 163 (2013), 678–680 Epub 2013 Sep 30.
55. [55] Berrone, E., Corona, C., Mazza, M., Vallino Costassa, E., Lo Faro, M., Properzi, F., et al. Detection of cellular prion protein in exosome derived from ovine plasma. J Gen Virol 96 (2015), 3698–3702.
56. [56] Properzi, F., Logozzi, M., Abdel-Haq, H., Federici, C., Lugini, L., Azzarito, T., et al. Detection of exosomal prions in blood by immunochemistry techniques. J Gen Virol 96 (2015), 1969–1974 Epub 2015 Mar 24.
57. [57] Akimov, S., Vasilyeva, I., Yakovleva, O., McKenzie, C., Cervenakova, L., Murine bone marrow stromal cell culture with features of mesenchymal stem cells susceptible to mouse-adapted human TSE agent, Fukuoka-1. Folia Neuropathol 47 (2009), 205–214.
58. [58] Cervenakova, L., Akimov, S., Vasilyeva, I., Yakovleva, O., McKenzie, C., Cervenak, J., et al. Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells. Transfusion 51 (2011), 1755–1768 Epub 2011 Feb 8.
59. [59] Fischer, M., Rülicke, T., Raeber, A., Sailer, A., Moser, M., Oesch, B., et al. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15 (1996), 1255–1264.
60. [60] Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.P., DeArmond, S.J., et al. Normal development and behaviour of mice lacking the neuronal cellsurface PrP protein. Nature 356 (1992), 577–582.
61. [61] Piccardo, P., Cervenakova, L., Vasilyeva, I., Yakovleva, O., Bacik, I., Cervenak, J., et al. Candidate cell substrates, vaccine production, and transmissible spongiform encephalopathies. Emerg Infect Dis 17 (2011), 2262–2269.
62. [62] Fraser, H., Dickinson, A.G., The sequential development of the brain lesions of scrapie in three strains of mice. J Comp Pathol 78 (1968), 301–311.
63. [63] Reed, L.J., Muench, H., A simple method of estimating fifty percent end points. Am J Hyg 7 (1938), 493–497.
64. [64] Thackray, A.M., Klein, M.A., Aguzzi, A., Bujdoso, R., Chronic subclinical prion disease induced by low-dose inoculum. J Virol 76 (2002), 2510–2517.
65. [65] Cosseddu, G.M., Nonno, R., Vaccari, G., Bucalossi, C., Fernandez-Borges, N., Di Bari, M.A., et al. Ultra-efficient PrPSc amplification highlights potentialities and pitfalls of PMCA technology. PLoS Pathog, 7, 2011, e1002370 Epub 2011 November 17.
66. [66] Barria, M.A., Mukherjee, A., Gonzalez-Romero, D., Morales, R., Soto, C., De novo generation of infectious prions in vitro produces a new disease phenotype. PLoS Pathog, 5, 2009, e1000421 Epub 2009 May 15. Correction in: PLoS Pathog. 2013; 9:10.
67. [67] Brown, P., Rohwer, R.G., Dunstan, B.C., MacAuley, C., Gajdusek, D.C., Drohan, W.N., The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38 (1998), 810–816.
68. [68] Brown, P., Cervenáková, L., McShane, L.M., Barber, P., Rubenstein, R., Drohan, W.N., Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 39 (1999), 1169–1178.
69. [69] Castilla, J., Saá, P., Soto, C., Detection of prions in blood. Nat Med 11 (2005), 982–985 Epub 2005 Aug 28.
70. [70] Cervenakova, L., Yakovleva, O., McKenzie, C., Kolchinsky, S., McShane, L., Drohan, W.N., et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 43 (2003), 1687–1694.
71. [71] Caradec, J., Kharmate, G., Hosseini-Beheshti, E., Adomat, H., Gleave, M., Guns, E., Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem 47 (2014), 1286–1292 Epub 2014 Jun 20.
72. [72] Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V., Vermaelen, K., Vandesompele, J., et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles, 3, 2014, 10 Epub 2014 September 18.
73. [73] Vandersande, J., Current approaches to the preparation of plasma fractions. Biotechnology 19 (1991), 165–176.
74. [74] McCutcheon, S., Alejo Blanco, A.R., Tan, B.C., González, L., Martin, S., Mallinson, G., et al. A prion reduction filter does not completely remove endogenous prion infectivity from sheep blood. Transfusion 55 (2015), 2123–2133 Epub 2015 May 30.
75. [75] Lescoutra-Etchegaray, N., Jaffré, N., Sumian, C., Durand, V., Correia, E., Mikol, J., et al. Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update. Transfusion 55 (2015), 1231–1241 Epub 2015 Feb 3.
76. [76] Yunoki, M., Tanaka, H., Urayama, T., Kanai, Y., Nishida, A., Yoshikawa, M., et al. Infectious prion protein in the filtrate even after 15 nm filtration. Biologicals 38 (2010), 311–313.
77. [77] Fraser, H., Dickinson, A.G., Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226 (1970), 462–463.
78. [78] Mould, D.L., Dawson, A.M., Rennie, J.C., Very early replication of scrapie in lymphocytic tissue. Nature 228 (1970), 779–780.
79. [79] Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., Wood, M.J.A., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29 (2011), 341–345 Epub 2011 Mar 20.
80. [80] Dragovic, R.A., Gardiner, C., Brooks, A.S., Tannetta, D.S., Ferguson, D.J., Hole, P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine (Lond) 7 (2011), 780–788 Epub 2011 May 4.
81. [81] Yuana, Y., Levels, J., Grootemaat, A., Sturk, A., Nieuwland, R., Coisolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation. J Extracell Vesicles, 3, 2014, 10 Epub 2014 July 8.
82. [82] Safar, J.G., Wille, H., Geschwind, M.D., Deering, C., Latawiec, D., Serban, A., et al. Human prions and plasma lipoproteins. Proc Natl Acad Sci USA 103 (2006), 11312–11317 Epub 2006 July 18.
83. [83] Scott, M.R., Peretz, D., Nguyen, H.O., Dearmond, S.J., Prusiner, S.B., Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol 79 (2005), 5259–5271.
84. [84] Morales, R., Duran-Aniotz, C., Diaz-Espinoza, R., Camacho, M.V., Soto, C., Protein misfolding cyclic amplification of infectious prions. Nat Protoc. Author manuscript; available in PMC 2014 June 9. Published in final edited form as: Nat Protoc 7 (2012), 1397–1409 Epub 2012 June 28.
85. [85] Parchi, P., Capellari, S., Chen, S.G., Petersen, R.B., Gambetti, P., Kopp, N., et al. Typing prion strains. Nature 386 (1997), 232–234.